An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...

Ahmedabad: Over the past 15 years, hundreds of patients, ranging from tiny infants just six months old to senior citizens nearing 80, have been part o.

A study published in the Journal of Cosmetic Dermatology explores the potential of Djon Djon, a unique mushroom fermented by ...

"After a while, I forgot that I was doing a remote surgery," Cleveland Clinic urologist Dr. Ruben Olivares said of EDAP's ...

In an effort to measure the toll of xylazine among people with opioid use disorders, The Inquirer examined patient billing records for millions of people admitted to Pennsylvania hospitals between ...

This study presents a valuable finding on the direct cytotoxic effects of DuoHexaBody-CD37 in diffuse large B-cell lymphoma, mediated via SHP-1 activation and antibody clustering, independent of ...

HOSPITAL bosses have apologised after an 11-week-old baby girl died following a series of devastating failure. Little Nova ...

Discover how excess weight silently damages your joints through both mechanical stress and inflammation, and learn effective ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...

Columnist Mary Shaniqua offers examples of some symptoms of sickle cell that are lesser known than fatigue and a ...

A parasite as long as 30cm has been found in a man's bladder, shocking. According to Live Science, a 35-year-old man living in Meerut, Uta Pradesh, India, visited the hospital when he was unable to ...

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...